Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.

@article{Orlandi1989HemorrhagicAT,
  title={Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.},
  author={Ester Maria Orlandi and Guglielmo Castelli and Ercole Brusamolino and Angelo Canevari and Enrica Morra and Mario Lazzarino and Carlo Bernasconi},
  journal={Haematologica},
  year={1989},
  volume={74 1},
  pages={45-9}
}
This study reviewed the clinical and hematologic characteristics of 161 patients with polycythemia vera treated with myelosuppressive agents, with or without antiaggregating platelet therapy, in order to determine the features associated with a risk of hemorrhagic or thrombotic complications. At presentation, 7 patients (4.3%) showed hemorrhages and 36 (22%) complained of thrombotic events. None of the evaluated clinical and hematologic parameters was significantly related to hemorrhagic or… CONTINUE READING